Foresite Capital Opportunity Management V, LLC Kinnate Biopharma Inc. Transaction History
Foresite Capital Opportunity Management V, LLC
- $33.3 Million
- Q3 2022
A detailed history of Foresite Capital Opportunity Management V, LLC transactions in Kinnate Biopharma Inc. stock. As of the latest transaction made, Foresite Capital Opportunity Management V, LLC holds 291,667 shares of KNTE stock, worth $0. This represents 10.46% of its overall portfolio holdings.
Number of Shares
291,667
Previous 291,667
-0.0%
Holding current value
$0
Previous $3.68 Million
5.25%
% of portfolio
10.46%
Previous 9.27%
Shares
1 transactions
Others Institutions Holding KNTE
# of Institutions
2Shares Held
292KCall Options Held
0Put Options Held
0About Kinnate Biopharma Inc.
- Ticker KNTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,145,600
- Description
- Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...